Drug Shortage Report for TOBRAMYCIN INHALATION SOLUTION
Report ID | 145010 |
Drug Identification Number | 02443368 |
Brand name | TOBRAMYCIN INHALATION SOLUTION |
Common or Proper name | TOBRAMYCIN INH |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 56 LIN |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-08-30 |
Estimated end date | Unknown |
Actual end date | 2021-08-08 |
Shortage status | Avoided shortage |
Updated date | 2021-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-09-14 | English | Compare |
v4 | 2021-09-02 | French | Compare |
v3 | 2021-09-02 | English | Compare |
v2 | 2021-09-02 | French | Compare |
v1 | 2021-09-02 | English | Compare |
Showing 1 to 5 of 5